跳至主要内容
临床试验/NCT04171479
NCT04171479已完成不适用

A Retrospective Multicenter Post-Market Clinical Follow-up Registry Comparing Safety and Effectiveness Outcomes of Epicardial Cardiac Ablation Using Remote Navigation to Manual Techniques

Stereotaxis3 个研究点 分布在 2 个国家目标入组 40 人开始时间: 2020年10月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Stereotaxis
入组人数
40
试验地点
3
主要终点
Procedural Safety: rates of device-and procedure-related serious adverse events

研究概览

简要总结

Retrospective registry will compare subjects who've undergone a mapping and/or ablation procedure for either ischemic ventricular tachycardia or premature ventricular contraction using an epicardial approach with either manual or remote magnetic navigation. Subjects will be compared with regards to safety, efficacy and mortality.

详细描述

Up to 10 centers in the European Union will be selected to conduct the trial. Once a site is a selected, receives local Ethics Committee approval, and receives Sponsor approval to enroll, the site will begin enrollment. All subjects must meet eligibility criteria and follow protocol and ethics committee requirements regarding informed consent prior to enrollment. Once a subject is enrolled, the site may begin reviewing the subject's medical records and entering data into the electronic data capture system. Once enrollment and retrospective data entry is complete at a site, a monitoring visit will occur where source data verification will occur.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Have undergone an epicardial RF mapping and/or ablation for a ventricular tachycardia (VT) as standard of care treatment using either the Niobe MNS or a manual approach
  • Index procedure was conducted between July 1, 2013-present date.

排除标准

  • NA, all subjects who meet inclusion criteria may be enrolled.

结局指标

主要结局

Procedural Safety: rates of device-and procedure-related serious adverse events

时间窗: 48 hours post index procedure

Assess rates of device-and procedure-related serious adverse events in both groups.

Acute Success

时间窗: intra-operative

Characterize acute success rates for both groups. Acute success for VT procedures is defined as non-inducibility of clinical VT and/or other monomorphic VT at the end of the index-procedure. Acute success for PVC procedures is defined as no recurrence and non-inducibility of culprit PVC at the end of the index-procedure.

次要结局

  • Mortality(1 year post index procedure)
  • Chronic Safety: rates of device-or procedure-related serious adverse events(At last follow up visit, estimated up to 6 years post-procedure for some patients)
  • Chronic Success(At last follow up visit, estimated up to 6 years post-procedure for some patients)

研究者

发起方
Stereotaxis
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

RMN Versus Manual Epicardial Retrospective PMCF | 临床试验